bioRxiv Science⌕ Search

Biology subjects

Rabbo, K. A.

Publications and source records attributed to Rabbo, K. A..

2 recordsLinked to original sources

Interpretable EEG Biomarkers for Neurological Disease Models in Mice Using Bag-of-Waves Classifiers

Electroencephalograms (EEGs) are time-series records of the electrical potential from collective neural activity in the brain. EEG waveform patterns--rhythmic and irregular oscillations and transient patterns of sharp waves or spikes--are potential phenotypical biomarkers, reflecting genotype-specific neural activity. This is especially relevant to diagnosing epilepsy without direct seizure observations, which is common in clinical settings, as well as in animal models, which often have subtle neurological phenotypes without overt epilepsy. Herein, we investigate genotypic prediction from long-term EEG signals of freely behaving mice belonging to six groups defined by the presence or absence of a neurological disease-genotype (TSC1 gene knockout) in three different inbred strains with distinct genetic backgrounds. The potential complexity of genotype-related EEG patterns motivates a machine learning approach to automatically extract time-series descriptors, such as waveforms or spectral content, as biomarkers. We propose a machine learning approach to predict the genotypes of individual mice from the occurrence counts of waveforms that approximate short windows of the EEG. That is, a dictionary of waveforms is optimized to approximate windows from each genotype, and the vectors of waveform occurrence counts are the features for predicting genotypes via logistic regression models. Across two-fold cross-validation of the waveform dictionary learning, and leave-one-individual-out genotype prediction, we find that waveform counts pooled over multiple hour segments enable reliable prediction of mouse strain with an accuracy of 70% (chance rate of 38%), and for two of the three strains, DBA2 and C57B6, strain-specific classifiers reliably determined the epilepsy-genotype (TSC1 gene knockout) at a 67% sensitivity with a 100% specificity for DBA2 and 67% specificity for C57B6. None of the mice of these strains had evidence of overt seizures or EEG-based seizure detection. The methodologies and results show the potential of EEG waveforms as phenotypes and bag-of-waves as a feature representation for identifying epilepsy genotypes.

neuroscience↗

Melanocortin 4 Receptor-Dependent Mechanism of ACTH in Preventing Anxiety-Like Behaviors and Normalizing Astrocyte Proteins After Early Life Seizures

Epilepsy, affecting millions globally, often leads to significant cognitive and psychiatric comorbidities, particularly in children. Anxiety and depression are particularly prevalent, with roughly a quarter of pediatric epilepsy patients having a comorbid diagnosis. Current treatments inadequately address these issues. Adrenocorticotropic hormone (ACTH), a melanocortin peptide, has shown promise in mitigating cognitive deficits after early life seizures (ELS), potentially through mechanisms beyond its canonical action on melanocortin 2 receptor (MC2R). This study explores the hypothesis that recurrent ELS is associated with long-term anxiety, and that treatment with ACTH can prevent this anxiety through a mechanism that involves melanocortin 4 receptors (MC4R) in the brain. Our findings reveal that ACTH ameliorates anxiety-like behavior associated with ELS, without altering seizure parameters, in wildtype (WT) mice but not in MC4R knockout (KO) mice. Our findings also show that knocking-in MC4R in either neurons or astrocytes was able to rescue the anxiety-like behavior after ACTH treatment. Further, our results show that ACTH normalizes important astrocytic proteins like Glial Fibrillary Acidic Protein (GFAP) and Aquaporin-4 (AQP4) after ELS. This suggests that ACTHs beneficial effects on anxiety are mediated through MC4R activation in both neuronal and astrocytic populations. This study underscores the therapeutic potential of targeting MC4R in epilepsy treatment, highlighting its role in mitigating cognitive impairments and anxiety-like behaviors associated with ELS.

neuroscience↗